Pasithea Therapeutics KTTAW SEC Filings

NASDAQ KTTAW
$0.00 0.00 (-36.36%)
As of: Sep 9, 2026 · 3:56 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Pasithea Therapeutics Corp. (KTTAW) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index